SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-061240
Filing Date
2018-11-21
Accepted
2018-11-21 16:09:48
Documents
3
Period of Report
2018-11-21

Document Format Files

Seq Description Document Type Size
1 6-K tv507746_6k.htm 6-K 12858
2 EXHIBIT 99.1 tv507746_ex99-1.htm EX-99.1 28251
3 GRAPHIC image_001.jpg GRAPHIC 7376
  Complete submission text file 0001144204-18-061240.txt   52548
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 181198307
SIC: 2834 Pharmaceutical Preparations